Aratana Therapeutics
Aratana Therapeutics is a Kansas-based pharmaceutical company that develops and commercializes small molecule therapeutics to treat osteoarthritis in pet animals.
Business Model:
Revenue: $38.7M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Aratana Therapeutics Information
Aratana Therapeutics was acquired by
Elanco.
The acquisition happend on 2019-04-26.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 11400 Tomahawk Creek Parkway
City: Leawood
State: KS
Zip: 66211
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$12M
Raised Total:$114M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Aratana Therapeutics is a Kansas-based pharmaceutical company that develops and commercializes small molecule therapeutics to treat osteoarthritis in pet animals.
Contact Phone:
+18447447389
Contact Email:
Aratana Therapeutics went public on 6/27/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/27/2013
IPO Valuation:
$223M
Ticker Symbol:
PETX
IPO Price:
$6/share
Amount Raised:
$35M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 1/2014 | Okapi Sciences | |
| 10/2013 | Vet Therapeutics |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
